You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SSTR2 antagonist

Showing 1 - 25 of 5,114
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma Trial in Xiamen (177Lu-EB-LM3 1, 177Lu-EB-LM3 2)

Recruiting
  • SSTR2-positive Tumors
  • 177Lu-LNC1010 1
  • +2 more
  • Xiamen, China
    The First Affiliated Hospital of Xiamen University
Nov 20, 2022

SSTR2, FAP, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT)

Recruiting
  • SSTR2
  • +2 more
  • 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
May 24, 2023

Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

Recruiting
  • Neuroendocrine Tumors
  • Innsbruck, Austria
  • +2 more
May 12, 2023

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

Not yet recruiting
  • Neuroendocrine Tumors
  • +8 more
  • Iowa City, Iowa
  • +1 more
Nov 23, 2022

Small Cell Lung Cancer and Breast Cancer Trial in Worldwide (Satoreotide tetraxetan, Satoreotide trizoxetan)

Terminated
Has Results
  • Small Cell Lung Cancer and Breast Cancer
  • Satoreotide tetraxetan
  • Satoreotide trizoxetan
  • Houston, Texas
  • +7 more
Aug 22, 2022

SCLC,Extensive Stage Trial in Omaha (RYZ101 Dose Level 1, RYZ101 Dose Level 2, RYZ101 Dose Level 3)

Recruiting
  • SCLC,Extensive Stage
  • RYZ101 Dose Level 1
  • +6 more
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Nov 18, 2022

SMART Protocol vs Antagonist Protocol in IVF

Active, not recruiting
  • Diminished Ovarian Reserve
    • Montreal, Quebec, Canada
      Clinique Ovo
    Dec 22, 2022

    Lung Cancer, Neuroendocrine Tumor Trial in Beijing (68Ga-NOTA-3P-TATE-RGD)

    Recruiting
    • Lung Cancer
    • Neuroendocrine Neoplasm
    • Beijing, Beijing, China
      Peking Union Medical College Hospitall, Chinese Academy of Medic
    Mar 30, 2022

    Healthy Trial in Madison (Selpercatinib, Ranitidine, Omeprazole)

    Completed
    • Healthy
    • Madison, Wisconsin
      Covance Clinical Research Unit, Inc.
    Jan 12, 2023

    Fibrolamellar Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, DRP-104)

    Not yet recruiting
    • Fibrolamellar Hepatocellular Carcinoma
    • Baltimore, Maryland
      Johns Hopkins SKCCC
    Aug 30, 2023

    Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

    Suspended
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Stanford, California
      Stanford Cancer Institute Palo Alto
    Sep 21, 2022

    Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)

    Recruiting
    • Safety Issues
    • +2 more
    • Washington, District of Columbia
      Georgetown University
    Dec 1, 2022

    Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 11, 2022

    in Vitro Fertilization, Poor Responder Trial in Toronto (metoclopramide)

    Withdrawn
    • in Vitro Fertilization
    • Poor Responder
    • Toronto, Ontario, Canada
      Mount Sinai Hospital
    Apr 7, 2022

    Blood Flow Trial in Copenhagen (GIPR antagonist / study tool, GLP-2R antagonist / study tool, Placebo)

    Recruiting
    • Blood Flow
    • GIPR antagonist / study tool
    • +2 more
    • Copenhagen, Denmark
      Rigshospitalet
    Nov 2, 2022

    Meningioma Trial in New York (Ga-68- DOTATATE, Ga-68-DOTATOC)

    Recruiting
    • Meningioma
    • New York, New York
      Weill Cornell Medical College of Cornell University
    Apr 10, 2022

    Spinal Cord Injuries, Myelopathy Trial in Cambridge (Istradefylline, low oxygen therapy)

    Not yet recruiting
    • Spinal Cord Injuries
    • Myelopathy
    • Cambridge, Massachusetts
      Spaulding Rehabilitation Hospital
    Jun 24, 2022

    COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

    Recruiting
    • COVID-19
    • SARS-CoV2 Infection
    • Candesartan Cilexetil
    • +3 more
    • Guntur, India
    • +4 more
    Mar 13, 2022

    Infertility Trial (10000 IU hCG (Choriomon5000 IU; IBSA), Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring))

    Not yet recruiting
    • Infertility
    • 10000 IU hCG (Choriomon5000 IU; IBSA)
    • Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring)
    • (no location specified)
    May 27, 2022

    Ovarian Stimulation Trial in Shibin Al Kawm (Letrozole 2.5mg tablet)

    Recruiting
    • Ovarian Stimulation
    • Letrozole 2.5mg tablet
    • Shibīn Al Kawm, Menoufia, Egypt
      Menoufia University hospital
    Dec 8, 2021

    Meningioma Trial in Basel (177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over), 177Lu-DOTATOC (Phase 0); Cycle 1 and

    Recruiting
    • Meningioma
    • 177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over)
    • +2 more
    • Basel, Basel-Stadt, Switzerland
      University Hospital Basel, Department of Neurosurgery
    Aug 2, 2021

    Type 2 Diabetes, Glucose Tolerance Impaired, Insulin Sensitivity Trial in San Antonio (REMD-477, Placebo Subcutaneous injection)

    Recruiting
    • Type 2 Diabetes
    • +2 more
    • San Antonio, Texas
      Texas Diabetes Institute
    Dec 22, 2021

    Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise

    Active, not recruiting
    • Exercise
    • Histamine
    • Placebo: Placebo + exercise training.
    • +2 more
    • Ghent, Oost-Vlaanderen, Belgium
      Department of movement and sports sciences, Ghent University, Be
    Nov 8, 2022

    Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for

    Active, not recruiting
    • Heavy Menstrual Bleeding
    • Fibroid Uterus
    • Groups 1 and 2 myomectomy and uterine artery embolization, respectively, are surgical/procedure
    • Elagolix Oral Product
    • Washington, District of Columbia
      MedStar Washington Hospital Center
    Apr 29, 2022

    Neuroendocrine Tumors Trial in Portland (Cabozantinib, Lu-177)

    Not yet recruiting
    • Neuroendocrine Tumors
    • Portland, Oregon
      Providence Portland Cancer Institute - Franz Clinic
    Feb 10, 2022